Gliptin-associated Bullous Pemphigoid and the Expression of Dipeptidyl Peptidase-4/CD26 in Bullous Pemphigoid

• Auteurs principaux: Outi Lindgren (Auteur), Outi Varpuluoma (Auteur), Jussi Tuusa (Auteur), Jorma Ilonen (Auteur), Laura Huilaja (Auteur), Nina Kokkonen (Auteur), Kaisa Tasanen (Auteur)
• Format: Livre
• Publié: Medical Journals Sweden, 2019-03-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Dipeptidyl peptidase-4 inhibitors (DPP-4i or gliptins) increase the risk of developing bullous pemphigoid (BP). To clarify, whether gliptin-associated BP has special features, we analyzed the clinical, histopathological and immunological features of 27 BP patients, 10 of which previously used glipti...